Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Letter from the Editor
About 5 months ago, we got a new couch and it is really comfortable. One end has a chaise lounge and it is great for watching Amazon Prime. I love to come in, make a nice cappuccino, and lie back and watch my current binge series “Covert Affairs.” Then suddenly I am ready for bed and I have watched 4 episodes. This sitting on the couch has taken its toll as I started noticing my back hurting when I would ride. After a quick trip to the physical therapist, he told me to get off the couch and either stand or rock on a Pilates ball. Technology has made a lot of great things, but increasing the time we sit on the sofa is not one of them. This week, our activity guru, Dr. Sheri Colberg, shares real data and facts that will back up what I am saying.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
Newsflash: t:slim Gets FDA Approval
The FDA granted Tandem Diabetes Care approval for its t:slim X2 insulin pump with Dexcom’s G5 mobile continuous glucose monitor, which allows for treatment decision-making without the need for a finger prick. See New Product info.
This Week's Survey
Because the A1c test is important for more than diagnosing diabetes and prediabetes, it is important that we each know what our A1c is. Do you know what your A1c number is?
Follow the link to share your response!
Current Interview: Diabetes Self-Management
Dr. Linda Siminerio RN, PhD is a Professor of Medicine at the University of Pittsburgh and Executive Director of the University of Pittsburgh Diabetes Institute. Dr. Siminerio has organized 44 diabetes self-management education programs throughout western Pennsylvania and for the U.S. military at Wilford Hall Medical Center at the Lackland Air Force Base in Texas. Dr. Siminerio’s primary research topics include diabetes education, diabetes translation into community interventions, pediatric diabetes care and education, and the psychosocial and behavioral aspects of diabetes.
New Product: Tandem's t:slim X2 insulin Pump with Dexcom G5 CGM
The FDA granted Tandem Diabetes Care approval for its t:slim X2 insulin pump with Dexcom’s G5 mobile continuous glucose monitor, which allows for treatment decision-making without the need for a finger prick.
The software will be made available at no extra cost by Tandem to existing t:slim X2 users to allow them to add CGM integration to their current pumps. The easy-to-use pump is compatible with the Dexcom G5 Mobile CGM. Only needs 2 finger sticks a day for the CGM and lasts for 7 days. Transmit real time glucose data to the compatible mobile device and it can be shared with others. The device features programmable high and low alert settings that notify the wearer when their glucose is above or below their personal target range. T:slim X2
Test Your Knowledge
Acanthosis nigricans presents as a brown to black pigmentation usually seen in the neck or armpit areas. In relation to diabetes, this may indicate:
A) granuloma annulare
B) diabetic dermopathy
C) type 1 diabetes
D) insulin resistance
Follow the link to see the correct answer.
Did You Know: Weight Loss Associated With Greater Risk of Increased Mortality Than Weight Gain
A nationwide longitudinal study investigated the association between weight change and subsequent all-cause mortality, using a large-scale population-based between 2005 and 2015. A total of 11,524,763 subjects aged over 20 years were included. Weight was measured every two years and weight change over 4 years was divided into eight categories, from weight loss ≥15% to weight gain ≥20%, for every 5% of weight change. The hazard ratios (HRs) and 95% confidence intervals (CIs) for all-cause mortality were analyzed using multivariable Cox’s proportional hazard models compared to the stable weight group (weight change < 5kg) after adjusting for age, sex, smoking, drinking, exercise, diabetes mellitus, hypertension, dyslipidemia, cancer, and income. The results showed that weight loss was associated with increased mortality more than weight gain; the group with weight loss ≥15% had the highest HR for all-cause mortality (HR; 95% CI=2·598; 2·537-2·659). The HR for all-cause mortality in the ≥20% weight gain group was 1·784 (95% CI=1·695-1·877). Across all body mass index (BMI) categories, weight loss ≥15% was associated with increased mortality rates and the highest mortality rates were found in the BMI ≥30 kg/m2 group (HR; 95% CI=3·469; 2·236-5·381). From the results it was concluded that weight change over 4 years showed a reverse J-shaped all-cause mortality curve, independent of BMI status. — The Journal of Clinical Endocrinology and Metabolism (JCEM) Published Aug 2017
Make no mistake: sitting less time overall is a good idea for myriad health reasons, but is sitting as bad for you as some would suggest? Is it really the new smoking? In 2017 alone, a slew of new research studies has looked at various health detriments associated with prolonged sitting, even in adults who exercise regularly.
Technological support deemed beneficial for glycemic control
Is a single fasting glucose measurement sufficient to predict risk of adverse perinatal outcomes?
Carotid ultrasound shows atherosclerotic disease is not just a concern for patients with type 1 and type 2 diabetes, but LADA as well.
Quote of the Week!
“When you reach the end of your rope, tie a knot in it and hang on.”
…Franklin D. Roosevelt
Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletter:
Josephat Macharia, Doctor of Pharmacy Candidate: Class of 2018; LECOM College of Pharmacy
Jessica Lambert, Doctor of Pharmacy Candidate; USF College of Pharmacy
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com